Omalizumab

Common brands: Xolair, Xolair Pfs, Singulair, Prednisone, Prednisone Delayed Release

Top reporter: Genentech, Inc.

Anti-IgE [EPC]Corticosteroid [EPC]Nonsteroidal Anti-inflammatory Drug [EPC]Benzodiazepine [EPC]Catecholamine [EPC]
82,196
Total Reports
30,510
Serious Reports
2,420
Death Reports
30
Reported Reactions
Death Report Ratio: Moderate (2.94%)

Patient Demographics

Male
19,437
Female
54,333

Reported Adverse Reactions (30)

Side effects reported in FDA adverse event reports for Omalizumab.

# Reaction Reports % of Total
1 ASTHMA 11,893
7.5%
2 URTICARIA 10,855
6.9%
3 NO ADVERSE EVENT 10,552
6.7%
4 OFF LABEL USE 10,297
6.5%
5 DYSPNOEA 10,112
6.4%
6 DRUG INEFFECTIVE 8,032
5.1%
7 COUGH 6,930
4.4%
8 PRURITUS 6,122
3.9%
9 FATIGUE 5,957
3.8%
10 MALAISE 5,575
3.5%
11 WHEEZING 5,408
3.4%
12 HEADACHE 5,328
3.4%
13 PNEUMONIA 5,149
3.3%
14 PAIN 4,277
2.7%
15 ANAPHYLACTIC REACTION 4,175
2.6%
16 NASOPHARYNGITIS 3,914
2.5%
17 ARTHRALGIA 3,712
2.4%
18 HYPERSENSITIVITY 3,477
2.2%
19 WEIGHT DECREASED 3,448
2.2%
20 DIZZINESS 3,384
2.1%
21 RASH 3,277
2.1%
22 PYREXIA 3,214
2.0%
23 NAUSEA 3,077
2.0%
24 BLOOD PRESSURE INCREASED 2,998
1.9%
25 DRUG HYPERSENSITIVITY 2,915
1.8%
26 CHEST DISCOMFORT 2,853
1.8%
27 VOMITING 2,784
1.8%
28 INFLUENZA 2,739
1.7%
29 PRODUCT DOSE OMISSION ISSUE 2,666
1.7%
30 WEIGHT INCREASED 2,665
1.7%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.